These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17990348)

  • 1. Immunotherapy and immunoescape in colorectal cancer.
    Mazzolini G; Murillo O; Atorrasagasti C; Dubrot J; Tirapu I; Rizzo M; Arina A; Alfaro C; Azpilicueta A; Berasain C; Perez-Gracia JL; Gonzalez A; Melero I
    World J Gastroenterol; 2007 Nov; 13(44):5822-31. PubMed ID: 17990348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
    Amedei A; Niccolai E; Prisco D
    Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in immunotherapy for the treatment of colorectal cancer.
    Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
    J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell defects in the colorectal cancer.
    Legitimo A; Consolini R; Failli A; Orsini G; Spisni R
    Hum Vaccin Immunother; 2014; 10(11):3224-35. PubMed ID: 25483675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active specific immunotherapy for colorectal cancer.
    Indar AA; Maxwell-Armstrong CA
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):685-94. PubMed ID: 14599091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for colorectal cancer.
    Koido S; Ohkusa T; Homma S; Namiki Y; Takakura K; Saito K; Ito Z; Kobayashi H; Kajihara M; Uchiyama K; Arihiro S; Arakawa H; Okamoto M; Gong J; Tajiri H
    World J Gastroenterol; 2013 Dec; 19(46):8531-42. PubMed ID: 24379570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for colorectal cancer.
    Foon KA
    Curr Oncol Rep; 2001 Mar; 3(2):116-26. PubMed ID: 11177743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy for colorectal cancer].
    Tougeron D; Fauquembergue É; Latouche JB
    Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
    Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
    Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
    Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
    Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological therapy of colorectal cancer.
    de Kleijn EM; Punt CJ
    Eur J Cancer; 2002 May; 38(7):1016-22. PubMed ID: 11978526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of colorectal cancer: new perspectives after a long path.
    Correale P; Botta C; Ciliberto D; Pastina P; Ingargiola R; Zappavigna S; Tassone P; Pirtoli L; Caraglia M; Tagliaferri P
    Immunotherapy; 2016 Nov; 8(11):1281-1292. PubMed ID: 27993089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of colorectal cancer.
    Smith CL; Dulphy N; Salio M; Cerundolo V
    Br Med Bull; 2002; 64():181-200. PubMed ID: 12421733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for metastatic colorectal cancer: present status and new options.
    Ellebaek E; Andersen MH; Svane IM; Straten PT
    Scand J Gastroenterol; 2012 Mar; 47(3):315-24. PubMed ID: 22214467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience.
    Correale P; Cusi MG; Micheli L; Nencini C; Del Vecchio MT; Torino F; Aquino A; Bonmassar E; Francini G; Giorgi G
    Invest New Drugs; 2006 Mar; 24(2):99-110. PubMed ID: 16502353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody.
    Denton GW; Durrant LG; Hardcastle JD; Austin EB; Sewell HF; Robins RA
    Int J Cancer; 1994 Apr; 57(1):10-4. PubMed ID: 8150527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant immunotherapy for melanoma and colorectal cancers.
    Safa MM; Foon KA
    Semin Oncol; 2001 Feb; 28(1):68-92. PubMed ID: 11254868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.